東亞銀行(00023.HK)向友邦出售東亞人壽股份事項落實 東亞人壽將出表
格隆匯9月1日丨東亞銀行(00023.HK)公佈,就公司向友邦出售東亞人壽一事,售股和框架協議中所載明的出售事項的條件已全部達成。
出售事項已根據售股和框架協議的條款於2021年9月1日完成。根據售股和框架協議的條款,友邦已就購買東亞人壽股份,以及公司訂立及遵守區域分銷協議中的分銷安排,向公司支付現金代價約50.98億港元,包括由2020年9月30日起至交易完成期間所產生的利息。
自完成時起,公司不再持有東亞人壽的任何權益,因此,東亞人壽不再是公司的附屬公司,東亞人壽的財務業績將不再併入公司的財務報表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.